|
1
|
Li JS, Ying JM, Wang XM, et al: Promoter
methylation of tumor suppressor genes in esophageal squamous cell
carcinoma. Chin J Cancer. 32:3–11. 2013.
|
|
2
|
Sarbia M, Ott N, Pühringer-Oppermann F and
Brucher BL: The predictive value of molecular markers (p53, EGFR,
ATM, CHK2) in multimodally treated squamous cell carcinoma of the
oesophagus. Br J Cancer. 97:1404–1408. 2007.
|
|
3
|
Li C, Li Z, Zhu M, et al:
Clinicopathological and prognostic significance of survivin
over-expression in patients with esophageal squamous cell
carcinoma: a meta-analysis. PLoS One. 7:e447642012.
|
|
4
|
Kuo KT, Chow KC, Wu YC, et al:
Clinicopathologic significance of cyclooxygenase-2 overexpression
in esophageal squamous cell carcinoma. Ann Thorac Surg. 76:909–914.
2003.
|
|
5
|
Lehmann JM, Riethmuller G and Johnson JP:
MUC18, a marker of tumor progression in human melanoma, shows
sequence similarity to the neural cell adhesion molecules of the
immunoglobulin superfamily. Proc Natl Acad Sci USA. 86:9891–9895.
1989.
|
|
6
|
Ouhtit A, Gaur RL, Abd Elmageed ZY, et al:
Towards understanding the mode of action of the multifaceted cell
adhesion receptor CD146. Biochim Biophys Acta. 1795:130–136.
2009.
|
|
7
|
Melnikova VO, Balasubramanian K, Villares
GJ, et al: Crosstalk between protease-activated receptor 1 and
platelet-activating factor receptor regulates melanoma cell
adhesion molecule (MCAM/MUC18) expression and melanoma metastasis.
J Biol Chem. 284:28845–28855. 2009.
|
|
8
|
Wu GJ, Peng Q, Fu P, et al: Ectopical
expression of human MUC18 increases metastasis of human prostate
cancer cells. Gene. 327:201–213. 2004.
|
|
9
|
Aldovini D, Demichelis F, Doglioni C, et
al: M- CAM expression as marker of poor prognosis in epithelial
ovarian cancer. Int J Cancer. 119:1920–1926. 2006.
|
|
10
|
Zabouo G, Imbert AM, Jacquemier J, et al:
CD146 expression is associated with a poor prognosis in human
breast tumors and with enhanced motility in breast cancer cell
lines. Breast Cancer Res. 11:R12009.
|
|
11
|
Gabbert HZ, Shimoda T, Hainaut P, et al:
Tumours of the oesophagus. World Health Organization Classification
of Tumours: Pathology and Genetics of Tumours of the Digestive
System. Hamilton SR and Alaltonen LA: IARC Press; Lyon: pp. 10–16.
2000
|
|
12
|
TNM Classification of the Esophagus.
International Union Against Cancer; 6th edition. J Willy &
Sons; New York, NY: pp. 2–25. 2002
|
|
13
|
Wang W, Yang ZL, Liu JQ, Jiang S and Miao
XY: Identification of CD146 expression, angiogenesis, and
lymphangiogenesis as progression, metastasis, and poor prognosis
related markers for gallbladder adenocarcinoma. Tumour Biol.
33:173–182. 2012.
|
|
14
|
Luo Y, Zheng C, Zhang J, et al:
Recognition of CD146 as an ERM-binding protein offers novel
mechanisms for melanoma cell migration. Oncogene. 31:306–321.
2012.
|
|
15
|
Luca M, Hunt B, Bucana CD, et al: Direct
correlation between MUC18 expression and metastatic potential of
human melanoma cells. Melanoma Res. 3:35–41. 1993.
|
|
16
|
Johnson JP: Cell adhesion molecules in the
development and progression of malignant melanoma. 18:345–357.
1999.
|
|
17
|
Xie S, Luca M, Huang S, et al: Expression
of MCAM/MUC18 by human melanoma cells leads to increased tumor
growth and metastasis. Cancer Res. 57:2295–2303. 1997.
|
|
18
|
Zabouo G, Imbert AM, Jacquemier J, et al:
CD146 expression is associated with a poor prognosis in human
breast tumors and with enhanced motility in breast cancer cell
lines. Breast Cancer Res. 11:R12009.
|
|
19
|
Kristiansen G, Yu Y, Schluns K, et al:
Expression of the cell adhesion molecule CD146/MCAM in non-small
cell lung cancer. Anal Cell Pathol. 25:77–81. 2003.
|
|
20
|
Liu WF, Ji SR, Sun JJ, et al: CD146
Expression correlates with epithelial-mesenchymal transition
markers and a poor prognosis in gastric cancer. Int J Mol Sci.
13:6399–6406. 2012.
|
|
21
|
Shih I-M, Nesbit M, Herlyn M and Kurman
RJ: A new Mel-CAM (CD146)-specific monoclonal antibody, MN-4, on
paraffin-embedded tissue. Mod Pathol. 11:1098–1106. 1998.
|
|
22
|
Zeng Q, Li W, Lu D, et al: CD146, an
epithelial-mesenchymal transition inducer, is associated with
triple-negative breast cancer. Proc Natl Acad Sci USA.
109:1127–1132. 2012.
|
|
23
|
Tsai JH and Yang J: Epithelial-mesenchymal
plasticity in carcinoma metastasis. Genes Dev. 27:2192–2206.
2013.
|
|
24
|
Bardin N, Anfosso F, Masse JM, et al:
Identification of CD146 as a component of the endothelial junction
involved in the control of cell-cell cohesion. Blood. 98:3677–3684.
2001.
|
|
25
|
Delorme B, Ringe J, Gallay N, et al:
Specific plasma membrane protein phenotype of culture-amplified and
native human bone marrow mesenchymal stem cells. Blood.
111:2631–2635. 2008.
|
|
26
|
Tanaka T, Ishiguro H, Kuwabara Y, et al:
Vascular endothelial growth factor C (VEGF-C) in esophageal cancer
correlates with lymph node metastasis and poor patient prognosis. J
Exp Clin Cancer Res. 29:832010.
|
|
27
|
Sundar SS and Ganesan TS: Role of
lymphangiogenesis in cancer. J Clin Oncol. 25:4298–4207. 2007.
|
|
28
|
Nathanson SD: Insights into the mechanisms
of lymph node metastasis. Cancer. 98:413–423. 2003.
|
